AFP and hepatocellular carcinoma: Regarding AFP levels, a biomarker of HCC, the Chilean cohort displayed a median of 9.6 ng/mL (min–max: 1.3–505), the Rome cohort a median of 39.7 ng/mL (min–max: 2.3–3467), and the Florence cohort a median of 2.2 ng/mL (min–max: 1.7–4.4).